Tech Company Financing Transactions
Kaneq Bioscience Funding Round
Kaneq Bioscience, based in Montreal QC, received investment capital from TVM Capital.
Transaction Overview
Company Name
Announced On
1/23/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
TVM Capital (Cynthia Lavoie)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Montreal QC, H1A 0A1
Canada
Montreal QC, H1A 0A1
Canada
Phone
Undisclosed
Website
Email Address
Overview
Kaneq Bioscience Ltd. will tap into the rich ecosystem of service providers in the area to bring its asset to human proof-of-concept, including expertise provided by Montreal-based Chorus Canada, an offshoot of global-early-phase drug development network Chorus, an autonomous unit of Eli Lilly and Company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Bouthillier
Vice President
Cameron Black
Vice President
Brian Kennedy
Browse more venture capital transactions:
Prev: 1/23/2013: Leyden Energy venture capital transaction
Next: 1/23/2013: Goal Zero venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs